Medication info
Canarb 60 mg (Pimodisant Potassium Trihydrate)

Canarb 60 mg (Pimodisant Potassium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceuticals Co., Ltd.
Appearance
Yellow convex film-coated tablets with a division line on one side and rounded corners, in the shape of a hexagon.
Packaging
For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Approval status
Active

MFDS item code 201005501 · Approved 2010.09.09 · Insurance code 641905450

Summary

Main use
Treatment of essential hypertension; reduction of proteinuria in hypertensive patients with type 2 diabetic kidney disease
Who takes it
Adults · Children
Adult dose
1. Essential hypertension Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended that the medicine be taken at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks of starting treatment, with the maximum effect reached after approximately 8 weeks ~ 12 weeks. Elderly patients No adjustment of the initial dose is necessary for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, the recommended initial dose is 30 mg of this medicine once daily. (See section 9. Administration to elderly patients under Precautions for Use.) Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with 30 milligrams once daily and do not exceed 60 milligrams per day. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. Do not administer this medicine to patients with moderate ~ severe hepatic impairment (see sections 2. Patients Who Should Not Receive This Medicine and 10. Administration to Patients with Hepatic Impairment under Precautions for Use). Patients with decreased effective intravascular volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients Who Should Be Treated with Caution under Precautions for Use.) 2. Reduction of proteinuria in patients with hypertensive type 2 diabetic chronic kidney disease as a treatment for hypertension The usual dose is 60 milligrams of this medicine once daily, regardless of meals. The dose may be increased to 120 milligrams once daily depending on blood pressure. However, an initial dose of 30 milligrams is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with antidiabetic agents.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Ingredients

Manufacturer
Boryung Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction of proteinuria in hypertensive patients with type 2 diabetic kidney disease

  • Essential hypertension
  • hypertension
  • type 2 diabetic chronic kidney disease
  • proteinuria
View approved original text

This medication is used to effectively control blood pressure in patients with essential hypertension. In particular, it reduces proteinuria in patients with type 2 diabetes and chronic kidney disease, helping to protect kidney function. By managing blood pressure and related kidney complications, it improves overall health. Therefore, it is helpful in the treatment of hypertension and related kidney diseases.

How to take

Adult dose

1. Essential hypertension Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended that the medicine be taken at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks of starting treatment, with the maximum effect reached after approximately 8 weeks ~ 12 weeks. Elderly patients No adjustment of the initial dose is necessary for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, the recommended initial dose is 30 mg of this medicine once daily. (See section 9. Administration to elderly patients under Precautions for Use.) Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with 30 milligrams once daily and do not exceed 60 milligrams per day. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. Do not administer this medicine to patients with moderate ~ severe hepatic impairment (see sections 2. Patients Who Should Not Receive This Medicine and 10. Administration to Patients with Hepatic Impairment under Precautions for Use). Patients with decreased effective intravascular volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients Who Should Be Treated with Caution under Precautions for Use.) 2. Reduction of proteinuria in patients with hypertensive type 2 diabetic chronic kidney disease as a treatment for hypertension The usual dose is 60 milligrams of this medicine once daily, regardless of meals. The dose may be increased to 120 milligrams once daily depending on blood pressure. However, an initial dose of 30 milligrams is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with antidiabetic agents.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus or newborn, especially when taken during the second and third trimester of pregnancy, so it should be stopped immediately if pregnancy is confirmed. Patients who are allergic to any of the ingredients in this medication, who are pregnant or breastfeeding, or who have severe liver impairment or biliary obstruction should not take this medication. Particular caution should be exercised when using this medication in patients who have low blood volume or salt, impaired kidney function, renal artery hypertension, certain heart conditions, or primary hyperaldosteronism. Take care if allergic to dye Yellow No. 4 contained in this medication. During treatment, various side effects such as headaches, dizziness, indigestion, cough, and itchy skin may occur, and in rare cases, serious adverse reactions related to the nervous system, heart, gastrointestinal tract, and kidneys may also arise, so if symptoms are severe, consult healthcare professionals immediately. As this medication lowers blood pressure, there is a risk of excessively low blood pressure or electrolyte imbalances, particularly in patients taking high doses of diuretics, so caution is needed when starting or increasing the dose. Additionally, patients with heart failure or reduced kidney function should have regular blood tests due to the risk of increased potassium levels in the blood. When used in combination with other antihypertensives, diuretics, potassium-sparing diuretics, lithium, and non-steroidal anti-inflammatory drugs, drug interactions may occur, so consult a doctor or pharmacist. Pregnant or breastfeeding women should avoid this medication, particularly during early pregnancy, as it can affect the fetus. Safety and efficacy in children under 18 years have not been established, so its use is not recommended. Elderly patients aged 65 and over may be more sensitive to this medication; however, generally, dose adjustment is unnecessary but their condition should be closely monitored. Patients with severe liver impairment should not be administered this medication. In case of overdose, symptoms such as low blood pressure or arrhythmias may occur, requiring immediate treatment if symptoms arise. This medication should be kept out of reach of children, and transferring to another container may adversely affect quality.

Side effects

  • Headache
  • dizziness
  • fainting
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • abdominal pain
  • weakness
Show 159 more
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • elevated serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • cerebral infarction exacerbation
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified type
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • nephrolithiasis
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • fracture
  • chest pain
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional gastrointestinal disorder
  • gastroenteritis
  • frequent urination
  • difficulty urinating
  • hyperlipidemia
  • dyslipidemia
  • neck/shoulder pain
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • nosebleed
  • bronchitis
  • paresthesia
  • numbness
  • tremor
  • hypertonicity
  • panic reaction
  • Alzheimer's disease
  • suicide attempt
  • agitation
  • hyperthyroidism
  • hypothyroidism
  • elevated TSH
  • tachycardia
  • edema
  • peripheral edema
  • facial swelling
  • fatigue
  • fever
  • carpal tunnel syndrome
  • pulmonary tuberculosis
  • axillary pain
  • periorbital edema
  • allergy
  • chills
  • nasal polyp
  • pneumonia
  • hemoptysis
  • rhinitis exacerbation
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • sputum
  • bronchitis
  • hypercholesterolemia
  • diabetes
  • hypertriglyceridemia
  • thirst
  • diabetes exacerbation
  • calcinosis
  • hyponatremia
  • gout
  • eye pain
  • retinal disease
  • glaucoma
  • cataract
  • diplopia
  • floaters
  • uveitis
  • optic neuritis
  • visual disturbances
  • chronic renal failure exacerbation
  • cystitis
  • urinary tract infection
  • elevated BUN
  • abscess
  • bacterial infection
  • genital herpes
  • herpes labialis
  • shingles
  • thrombocytosis
  • panic reaction
  • Alzheimer's disease
  • suicide attempt
  • agitation
  • insomnia
  • depression
  • hyperthyroidism
  • hypothyroidism
  • elevated TSH
  • tachycardia
  • purpura
  • fatty liver

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container to protect it from light and air, at a temperature between 1 degree and 30 degrees Celsius. This storage method will help maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Yellow convex film-coated tablets with a division line on one side and rounded corners, in the shape of a hexagon.

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.